1.
Hematological malignant diseases rarely affect the uterine cervix as primary malignancies.
子宫颈原发性血液恶性疾病相当罕见。
2.
The Clinical Analysis of Autologous Haemapoiesis Stem Cell Transplantation Treats Malignant Hemacytological Disease 14 Cases;
自体外周血造血干细胞移植治疗恶性血液系统疾病14例临床研究
3.
Experimental Study on Anti-hematologic Malignancies of Extracts from Marsdenia Tenacissima
通关藤提取物抗恶性血液系统疾病作用的实验研究
4.
Malignant salivary gland tumors are uncommon and demonstrate wide diversity of histopathological types and biological behaviors.
恶性唾液腺肿瘤并不是个常见的疾病。
5.
The Study of Plasm suPAR Level in Malignant Hematologic Diseases;
恶性血液病血浆suPAR水平的临床研究
6.
The Results showed that 86 of 118(72.9%) malignant hempathy had NTIS.
结果显示，在118例恶性血液病中有86例存在非甲状腺疾病综合征，占72．9％。
7.
A clinical study of unrelated umbilical cord blood transplantation in pediatric patients with malignant and nonmalignant diseases
无关血缘脐血移植治疗儿童恶性和非恶性疾病的临床研究
8.
The Clinical Significance of Hemorheology Examination to Malignant Hematonosis
血液流变学检测对恶性血液病的临床意义
9.
Clinical Analysis of 61 Cases with Cancer and Thrombosis Disease;
恶性肿瘤并发血栓性疾病61例临床分析
10.
Expression and Significance of PTTG and b-FGF in Acute Leukemia and Multiple Myeloma;
PTTG与b-FGF在恶性血液病中的表达
11.
Methylation of the P～(15)INK4B Gene in Acute Leukemia and Myelodysplastic Syndromes;
恶性血液病中P～（15）基因甲基化的研究
12.
The Significance of GFI1B Expression in Malignant Hematologic Diseases
CFI1B在恶性血液病中的表达及意义
13.
Advances of Research on Demethylation Therapy for Hematologic Malignancies--Review
恶性血液病去甲基化治疗的研究进展
14.
Expression of AnnexinⅡ in Patients with Hematologic Malignancies
恶性血液病患者骨髓AnnexinⅡ基因的表达
15.
Application of SNP-Arrays in Hematological Malignancies--Review
SNP芯片技术在恶性血液病中的应用
16.
Analysis of nosocomial infection in 119 patients with hematological malignant disease
119例恶性血液病患者医院感染分析
17.
Wnt/β-catenin Signal Pathway and Malignant Hematological Disease--Review
Wnt/β-catenin信号通路与恶性血液病
18.
Significance of Marrow Histotomy in Diagnosing Malignant Hemology
骨髓活检在恶性血液病诊断中的意义